PHF6 and acute lymphoblastic leukemia: The first and most well-documented hematologic malignancy harboring mutations of PHF6 is T-lymphoblastic leukemia (T-ALL), with fewer cases identified in acute myeloid leukemia (AML), and rarer cases identified in pre-malignant clonal hematopoiesis (4, 21–23).